Project Details
| Status | Active |
|---|---|
| Effective start/end date | 9/1/17 → 9/30/27 |
Funding
- Quintiles Transnational Holdings Inc. (Prot #PCYC-1145-LT // Prot #PCYC-1145-LT)
- Pharmacyclics, Inc. (Prot #PCYC-1145-LT // Prot #PCYC-1145-LT)
Prot #PCYC-1145-LT: Extended treatment protocol for subjects continuing to benefit from ibrutinib after completion of ibrutinib clinical trials
- Ma, Shuo (PD/PI)
Project: Research project